Replies to post #347797 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Blind? Nope. We see beyond the horizon.

Are these perma bulls just blind? Someone question why the SP is red if the results is so good?

Well, by all accounts I’m an Anavex “perma bull.” I’ve been accumulating AVXLs for over five years; have been posting explanations of the successes and modalities Anavex science for that entire period. Virtually everything I’ve described or predicted about Anavex science has been demonstrated to be so; today it’s blarcamesine’s unique MOA (mechanism of action) on the sigma-1 receptor protein propelling propitious therapeutic outcomes in real humans.

The wild AVXL price swings certainly are interesting. They fit perfectly with the visions and understandings of the Anavex perma bears. Wonderful stuff — for day traders. Congratulations. We marvel.

But we longs don’t trade. We buy, then hold. Personally, I don’t care a wit about the day to day AVXL share price. I will wait and consider it in late 2023 or sometime in 2024; when blarcamesine is approved to treat Rett syndrome, Parkinson’s disease dementia, and finally, Alzheimer’s.

Day-trading bears can work the varying AVXL share price simply because Anavex Life Sciences Corp has no revenue streams. Presently, the company is a biotech or pharma start-up. Until there’s a revenue stream, everything related to the daily share price is speculation; most of it negative; as demonstrated by the AVXL share price just this minute.

Tonight, like most of my perma bull compatriots, I’ll sleep even a bit better. Sometime today, for fun, I’ll start punching in new anticipated Anavex revenue streams in 2024 and the years on out. Soon enough (for us longs), the AVXL share price will be stated in four digits before decimal point.